Showing results (301-310 of 384) with videos related to
Sort By:
Pageof 39
Journal of Neurobiology|September 1, 1995
Red-light-induced suppression of melatonin synthesis is mediated by N-methyl-D-aspartate receptor activation in retinally normal and retinally degenerate ratsB H Poeggeler, L R Barlow-Walden, R J Reiter, et al.Cell Cycle (Georgetown, Tex.)|April 4, 2013
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cellsJavier A Menendez, Jorge Joven, Sílvia Cufí, et al.Cell Cycle (Georgetown, Tex.)|October 11, 2013
Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cellsAlejandro Vazquez-Martin, Sílvia Cufí, Eugeni López-Bonet, et al.Aging|July 28, 2012
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugsBruna Corominas-Faja, Rosa Quirantes-Piné, Cristina Oliveras-Ferraros, et al.International Journal of Oncology|April 2, 2011
Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3Cristina Oliveras-Ferraros, Salvador Fernández-Arroyo, Alejandro Vazquez-Martin, et al.Cell Cycle (Georgetown, Tex.)|September 20, 2013
Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibininBruna Corominas-Faja, Cristina Oliveras-Ferraros, Elisabet Cuyàs, et al.Plos One|October 15, 2013
Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherinJuan Manuel Iglesias, Izaskun Beloqui, Francisco Garcia-Garcia, et al.Cytometry. Part B, Clinical Cytometry|January 6, 2007
Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methodsLance E Hultin, Frederick A Menendez, Patricia M Hultin, et al.Oncotarget|June 10, 2014
Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatmentJavier A Menendez, Rosa Quirantes-Piné, Esther Rodríguez-Gallego, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 26, 2019
Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammationFedra Luciano-Mateo, Noemí Cabré, Salvador Fernández-Arroyo, et al.Pageof 39